Moolec Science Achieves One of the Highest Commercial-Scale GLA Concentrations From U.S. GLASO1 Crushing

Stock Information for Moolec Science SA

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Moolec Science SA

Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions
Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement
Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement
Moolec Science Announces Effectiveness of Share Consolidation
Moolec Receives Staff Determination Letter and Provides Update on Nasdaq Listing Compliance Status
Moolec Science SA Announces the Implementation of a Share Consolidation of Its Ordinary Shares, Par Value U.S.$0.10 Per Share (the "Shares")
Moolec Science Scales GLASO U.S. Platform With Record 2025 Campaign and Expansion Into Nutrition & Supplements Market
Moolec Receives Nasdaq Determination Letter

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.